February 2021, Volume 71, Issue 2

Research Articles

Vitamin C and IL-6 level during third trimester of pregnancy with preeclampsia

Authors: Metta Dewi  ( Undergraduate Medical Student, Universitas Indonesia, Jakarta, Indonesia )
Saptawati Bardosono  ( Department of Clinical Nutrition, Universitas Indonesia, Jakarta, Indonesia )
Jeremy Rafael Tandaju  ( Undergraduate Medical Student, Universitas Indonesia, Jakarta, Indonesia )


Objective: To investigate the relationship between vitamin C intake and IL-6 level as a biomarker of oxidative stress during pregnancy.

Methods: Fourty pregnant women during third trimester were grouped into preeclampsia and non-preeclampsia, and surveyed using a Food Frequency Questionnaire. The ELISA assay for IL-6 expression was performed. Univariate and bivariate analyses were conducted using SPSS software ver. 20.

Results: Subjects in preeclampsia group were shown to consume slightly more vitamin C than the non-preeclampsia group, with median values of 76.37 (28.05 - 96.88) mg and 68.87 (8.57 - 198.53) mg, respectively (p = 0.36). A nonparametric correlation test showed no significant association between vitamin C and total IL-6 level, with p = 0.36 and r = -0.15. There was also no difference between vitamin C consumption and IL-6 level for each group, with r = -0.14 and r = -0.20, respectively.

Conclusion: There was no statistically significant association between vitamin C intake and IL-6 level in women during third trimester of pregnancy (p = 0.36).

Keywords: Interleukin-6, Pre-eclampsia, Pregnancy trimesters, Ascorbic acid. (JPMA 71: S-90 [Suppl. 2]; 2021)




Inflammation is often associated with disease, however, it could also be found under normal physiological conditions, such as pregnancy.1 The inflammatory response during normal pregnancy is primarily caused by increasing systemic oxidative stress due to the production of free radical species.2 The reactive species are abnormally generated by mitochondria, which are abundant in placenta.3 These reactive species induce cell apoptosis and necrosis that further attracts immune cells, such as leucocytes, to respond against damaged cells through the production of interleukin-1 (IL-1), interleukin-6 (IL-6) and tumour necrosis factor alpha (TNF-a).4

Oxidative stress is strongly associated with preeclampsia, one of the complications manifested during pregnancy.5 Signs of preeclampsia include hypertension and proteinuria. These signs usually occur at gestational age of 20 weeks or later. Studies indicated that preeclampsia is closely related to increased IL-6 levels.4,6,7 The ultimate complication caused by preeclampsia and oxidative stress is an increased risk of death from pregnancy as well as delivery. Globally, up to 830 women die from preeclampsia every day.8 Most of them are from developing countries, including Indonesia especially, where 359 out of 100,000 women died during delivery in 2012.9

In order to decrease mortality rate during delivery caused by oxidative stress, the role of antioxidants to neutralise excessive free radical production should be considered. Vitamin C, also known as ascorbic acid, is a low molecular weight carbohydrate with an enediol structure. Hence, it is a potent electron donor that could provide antioxidant protection against preeclampsia-related oxidative stress. Daily intake of vitamin C is obtained by consuming fruits and vegetables, as well as enriched foods and beverages.10,11

Studies have shown that there is a strong correlation between vitamin C intake and decreased IL-6 levels in pregnant women. However, others have stated that vitamin C intake was not sufficient to prevent complications due to preeclampsia during pregnancy and delivery.2,11 These conditions have made researchers wonder whether vitamin C intake affects IL-6 status during third trimester of pregnancy. Therefore, this study aims to evaluate the relationship between vitamin C and IL-6 level as a biomarker of oxidative stress during pregnancy.


Subjects and Methods


This hospital-based cross-sectional study was conducted in polyclinic and emergency unit of Department of Obstetrics and Gynaecology at Cipto Mangunkusumo National General Hospital from August 2018 to October 2018 under the approval of the Health Research Ethics Committee FKUI-RSCM no. LB.02/2.2/10796/2018. The study participants included women during third trimester of pregnancy (28 - 42 weeks gestational age) aged 18 years or older with a single, living, intrauterine pregnancy. All participants were required to provide written informed consent. The exclusion criteria included smokers and women with infectious diseases. Subjects were divided into two groups: women diagnosed with preeclampsia and women without preeclampsia. Since this is a preliminary study, the researchers decided to use 0.6 as the medium correlation coefficient, which resulted in 20 subjects being required for each group using consecutive sampling.

Eligible subjects had their peripheral blood drawn for IL-6 measurement using the ELISA assay. In addition, patients were interviewed using a semi-quantitative Food Frequency Questionnaire (FFQ) to assess their daily vitamin C intake. The data collected from FFQ were then processed using NutriSurvey programme by EBISPro to quantify each participant's vitamin C intake. All variables were then analysed using Statistical Package for Social Sciences (SPSS) ver. 20 for Windows by IBM: New York.

The data obtained were initially assessed with Shapiro-Wilk test to determine their data distribution. Additionally, age, gestational age, vitamin C intake and IL-6 level between different groups of patients were analysed using either independent t-test for normal data or Mann-Whitney and Chi-square tests for non-normal data. The test for correlation between vitamin C intake and IL-6 level was obtained using Spearman correlation.




This study included 40 women during third trimester of pregnancy at Cipto Mangunkusumo National General Hospital in Jakarta, Indonesia. They were divided into preeclampsia group and non-preeclampsia group. Age and gestational age variables were described as part of the inclusion criteria. The detailed characteristics of subjects are reported in Table-1.

The mean age of the women in preeclampsia group was 30.9±7.9 years, while mean age of women in non-preeclampsia group was 29.6 ± 5.4 years. This difference was not statistically significant (p = 0.55). In addition, women admitted into hospital had a status quo of third trimester pregnancy (shown in Table-2), which was proven by lack of statistically significant difference in gestational age between the groups (p = 0.34).

It was found that subjects in preeclampsia group consumed slightly more vitamin C than those in non-preeclampsia. The medians were 76.4 mg/day with a range of 28.0 - 396.9 mg/day and 68.9 mg/day with a range of 8.6 - 198.0 mg/day, respectively. This difference was not statistically significant (p = 0.36). The median IL-6 level in non-preeclampsia group was 6.8 pg/mL with a range of 1.8 - 43.5 pg/mL. The preeclampsia group had a much higher IL-6 level with median 15.8 pg/mL (2.2 - 67.4 pg/mL), but the difference was not statistically significant (p = 0.16). However, considering large value difference between the groups, it could be concluded that IL-6 level was clinically significant.

To measure the association between vitamin C intake and IL-6 level, a Spearman correlation test was conducted.

Table-3 shows no significant association between vitamin C and IL-6 level for all subjects, with p = 0.36 and r = -0.15. There was also no association between vitamin C and IL-6 level in each preeclampsia and non-preeclampsia groups with p = 0.55; r = -0.14 and p = 0.40; r = -0.20, respectively.




Preeclampsia is a multisystem disorder that occurs in pregnancy.12 Few of the features of this syndrome are hypertension and proteinuria. Based on age distribution, subjects with preeclampsia had a slightly higher mean age than non-preeclampsia subjects, but the difference was not statistically significant. Research conducted by Kumari et al., found contrasting result. They found significant association between preeclampsia and maternal age with p = 0.01. Preeclampsia was observed more often in extreme maternal ages, such as younger than 20 years or older than 35 years.13-15 In terms of gestational age, the current study showed no statistically significant difference between preeclampsia and non-preeclampsia groups. Preeclampsia occurred at gestational age greater than 20 weeks and mostly during third trimester. This study is similar to a research conducted in Romania where preeclampsia group recorded lower gestational age than non-preeclampsia group. The medians were 38 weeks with a range of 29 - 41 weeks and 39 weeks with a range of 32 - 42 weeks, respectively.16

Vitamin C intake in subjects with preeclampsia was higher than in non-preeclampsia group (p = 0.36). However, neither of the groups had what is considered adequate vitamin C intake of 85 mg per day or more. Antioxidants are very important during pregnancy as mothers usually experience more oxidative stress than women who are not pregnant. Therefore, there may be a greater demand for higher levels of vitamin C. Lack of antioxidants, such as vitamin C causes an inadequate bodily response to oxidative stress. Klemmensen et al., stated that severe preeclampsia could be prevented by a daily vitamin C intake of between 130 and 170 mg.17 A study conducted by Zhang also supported this finding. Pregnant women with inadequate vitamin C intake were two to 3.8 times more likely to develop preeclampsia than women with adequate vitamin C intake.18

Lack of fruit and vegetable consumption was reported to be one of the causes of inadequate vitamin C intake in pregnant women. The other was food processing, which causes vitamin C to be lost from food and beverages. In addition, area of residence, age, education and socio-economic status also acted as risk factors for vitamin C deficiency in pregnant women.19

IL-6 levels vary among individuals. This study showed IL-6 level in preeclampsia group to be two times higher than in non-preeclampsia group (Table-2). This difference was not statistically significant (p = 0.16). Similar results were reported by Tarnowska-Madra et al.,20 who found that pregnant women with preeclampsia had a higher IL-6 level of 35.5 ± 21.0 pg/ml compared to women without preeclampsia, whose level was 19.8 ± 12.3 pg/ml. Vitoratos et al.,21 found IL-6 level in preeclampsia group to be 2.66 ± 1.37 pg/ml, while it was 2.44 ± 0.85 pg/ml in non-preeclampsia group. This difference was not statistically significant. Conversely, studies conducted in Nigeria22 and Romania16 found statistically significant differences. The IL-6 level of preeclampsia group was two to eight times higher than the normal pregnancy group. This also correlated with severity of preeclampsia. Although there is no normal level of IL-6, all studies suggested that preeclamptic women have higher IL-6 levels than non-preeclamptic women with normal pregnancies.

Results of Pearson non-parametric correlation test showed that vitamin C reduced IL-6 levels in all subjects with r = -0.15. The same results were also acquired in preeclampsia and non-preeclampsia groups where vitamin C reduced IL-6 levels, with r = -0.14 and r = -0.20, respectively. However, the correlation value acquired was relatively low, and there were no significant results in three correlation tests. Although, to the best of authors' knowledge, there were no studies evaluating correlation between vitamin C and IL-6 levels in preeclamptic women; studies linking vitamin C with IL-6 levels in other diseases, such as metabolic and cardiovascular diseases, have been conducted. A study by Mikirova et al., showed no significant effects of intravascular vitamin C administration on IL-6 levels of mRNA from mononuclear cells in metabolic diseases.23 Those results are different from a study conducted in Palestine, which found that 500 mg vitamin C supplementation for eight weeks reduced IL-6 levels significantly in hypertensive or obese patients with diabetes (p = 0.001).24 It should be noted that the study by Mikirova et al., had a limitation, i.e., shorter intervention time when compared to the study in Palestine.

Theoretically, vitamin C should be able to reduce IL-6 levels and decrease inflammation as well as oxidative stress. Vitamin C is a potent antioxidant and is easily acquired from many sources. Due to its role as an electron donor, it has the potential to stabilise free radicals. Decreasing free radicals might also ameliorate oxidative stress that augments inflammation process. Inflammation and oxidative stress are basis of many pregnancy complications, including preeclampsia. The reduction of inflammation may also reduce the expression of proinflammatory cytokines, such as IL-6.5,6,11 This theory is supported by studies conducted by Klemmensen and Zhang, which found that pregnant women with higher vitamin C intake had a lower risk of developing preeclampsia.17,18 Another study conducted by Ellulu found that 500 mg daily vitamin C supplementation could significantly reduce IL-6 levels in hypertensive, diabetic and obese patients.24

The similar correlation coefficients between the two groups in this study might have shown that vitamin C could reduce IL-6 levels in both preeclamptic and non-preeclamptic women, but no significant correlation was shown by statistics. This could be due to inadequate vitamin C intake in both preeclamptic and non-preeclamptic groups. A study conducted by Klemmensen showed that severe preeclampsia could be ameliorated by daily vitamin C intake of between 130 and 170 mg.17 The disparity of vitamin C daily dose in the study by Klemmensen and this study (less than 85 mg daily) is actually quite great, given that vitamin C intake shown in this study is below the recommended dietary allowance (RDA). Besides that, the physiological increase of IL-6 levels during third trimester of pregnancy in order to aid the process of delivery might also be a plausible reason for lack of statistically significant results in this study. From another perspective, this study only addressed the correlation between vitamin C and IL-6 as an inflammatory marker, whereas free radical scavenging activities are not only performed by vitamin C but also other exogenous antioxidants, such as vitamin A and E, and endogenous antioxidants, such as glutathione and manganese superoxide dismutase (MnSOD).25 To summarise, the role of other antioxidants could not be excluded. It should then also be taken into account that the subjects in this study were not matched subjects but had various medical histories of acute and/or chronic diseases, as well as, other pregnancy complications. Those conditions could potentially be associated with more severe inflammation and unpredictable comorbidities when compared with normal pregnant women.

Knowing that inflammation in pregnancy is a physiological process and excessive inflammation could lead to complications in pregnancy, adequate antioxidant intake is suggested for all pregnant women. Vitamin C is an example of an antioxidant, which could easily be acquired from fruits and vegetables. Foods high in vitamin C include citrus fruits, such as oranges, mangoes, papayas, guavas; and vegetables, including broccoli, spinach and lettuce. In addition to vitamin C, adequate intake of other antioxidants, such as vitamin A and E, would give the best results in reducing free radicals and inflammation.

Although many studies discussing vitamin C and IL-6 have been conducted, studies that correlate vitamin C and IL-6 levels in preeclamptic women during third trimester have not yet been performed. Albeit with lack of statistically significant results, this study could be considered preliminary research. The authors hope this study could help society in realising the importance of fulfilling the RDA for antioxidants, especially vitamin C as an anti-inflammatory agent.

Like other studies in general, this study has limitations. One of its limitations is that it used a semi-quantitative FFQ because subjects tend to forget about food and portion size eaten for the past month. In addition, the sample size in this study is relatively small, which resulted in lack of statistical strength to identify very small differences. The other limitation of this study is its location at the Cipto Mangunkusumo National General Hospital, which is national referral hospital in Indonesia. Because there are more complex disease histories and comorbidities at this hospital that could affect study results, caution should be exercised when extrapolating these results to general population. Finally, the cross-sectional design of this study is another limitation as it is unable to truly demonstrate cause effect relationship between vitamin C and IL-6 levels.




From the results of this study, it could be summarised that vitamin C did not correlate with IL-6 statistically in preeclampsia and non-preeclampsia groups or in total. Since vitamin C intake of pregnant women failed to fulfil RDA and increasing IL-6 levels demonstrated severe inflammation, it is suggested that pregnant women should be offered education and counselling to encourage meeting the daily requirements of vitamins A, C, E and other exogenous antioxidants through fruit and vegetable consumption.


Acknowledgement: None to declare.

Disclaimer: None to declare.

Conflict of Interest: None to declare.

Funding Disclosure: This research was fully funded by a PITTA grant from Universitas Indonesia (grant aimed to encourage Universitas Indonesia students in publishing their research to international indexed journal).




1.      Palm M, Axelsson O, Wernroth L, Larsson A, Basu S. Involvement of inflammation in normal pregnancy. Acta Obstet Gynecol Scand 2013;92:601-5. doi: 10.1111/aogs.12093.

2.      Arulselvan P, Fard MT, Tan WS, Gothai S, Fakurazi S, Norhaizan ME, et al. Role of Antioxidants and Natural Products in Inflammation. Oxid Med Cell Longev 2016;2016:e5276130. doi: 10.1155/2016/5276130.

3.      Betteridge DJ. What is oxidative stress? Metabolism 2000;49(Suppl 1):3-8. doi: 10.1016/s0026-0495(00)80077-3.

4.      Prins JR, Gomez-Lopez N, Robertson SA. Interleukin-6 in pregnancy and gestational disorders. J Reprod Immunol 2012;95:1-14. doi: 10.1016/j.jri.2012.05.004.

5.      Duhig K, Chappell LC, Shennan AH. Oxidative stress in pregnancy and reproduction. Obstet Med 2016;9:113-6. doi: 10.1177/1753495X16648495.

6.      Bernardi F, Guolo F, Bortolin T, Petronilho F, Dal-Pizzol F. Oxidative stress and inflammatory markers in normal pregnancy and preeclampsia. J Obstet Gynaecol Res 2008;34:948-51. doi: 10.1111/j.1447-0756.2008.00803.

7.      Casanueva E, Viteri FE. Iron and oxidative stress in pregnancy. J Nutr 2003;133(Suppl 2):s1700-8. doi: 10.1093/jn/133.5.1700S.

8.      World Health Organization. Maternal mortality. News release. The WHO's Media Centre. [Online] 2018 [Cited 2018 April 12]. Available from URL: http://www.who.int/mediacentre/factsheets/fs348/en/

9.      Ministry of Health of the Republic of Indonesia. Infodatin: maternal health situation. [Online] 2014 [Cited 2018 April 12]. https://www.kemkes.go.id/folder/view/01/structure-publikasi-pusdatin-info-datin.html

10.    Lykkesfeldt J, Michels AJ, Frei B. Vitamin C. Adv Nutr 2014;5:16-8. doi: 10.3945/an.113.005157.

11.    Padayatty SJ, Katz A, Wang Y, Eck P, Kwon O, Lee JH, et al. Vitamin C as an antioxidant: evaluation of its role in disease prevention. J Am Coll Nutr 2003; 22: 18-35. doi: 10.1080/ 07315724.2003.10719272.

12.    Kongwattanakul K, Saksiriwuttho P, Chaiyarach S, Thepsuthammarat K. Incidence, characteristics, maternal complications, and perinatal outcomes associated with preeclampsia with severe features and HELLP syndrome. Int J Womens Health 2018;10:371-7. doi: 10.2147/IJWH.S168569.

13.    Kumari N, Dash K, Singh R. Relationship between Maternal Age and Preeclampsia. IOSR Journal of Dental and Medical Sciences 2016;15:55-7. DOI: 10.9790/0853-1512085557

14.    Zibaeenezhad MJ, Ghodsi M, Arab P, Gholzom N. The prevalence of hypertensive disorders of pregnancy in Shiraz, Southern Iran. Iran Cardiovasc Res J 2010;4:169-72.

15.    Sajith M, Nimbargi V, Modi A, Sumariya R, Pawar A. Incidence of pregnancy induced hypertension and prescription pattern of antihypertensive drugs in pregnancy. Int J Pharma Sci Res 2014;5:163-70.

16.    Mihu D, Razvan C, Malutan A, Mihaela C. Evaluation of maternal systemic inflammatory response in preeclampsia. Taiwan J Obstet Gynecol 2015;54:160-6. doi: 10.1016/j.tjog.2014.03.006.

17.    Klemmensen A, Tabor A, Østerdal ML, Knudsen VK, Halldorsson TI, Mikkelsen TB, et al. Intake of vitamin C and E in pregnancy and risk of pre-eclampsia: prospective study among 57 346 women. BJOG 2009;116:964-74. doi: 10.1111/j.1471-0528.2009.02150.x.

18.    Zhang C, Williams MA, King IB, Dashow EE, Sorensen TK, Frederick IO, et al. Vitamin C and the risk of preeclampsia--results from dietary questionnaire and plasma assay. Epidemiology 2002;13:409-16. doi: 10.1097/00001648-200207000-00008.

19.    Astriningrum EP, Hardinsyah H, Nurdin NM. Intake of folic acid, vitamin B12 and vitamin C among pregnant women in Indonesia based on Total Diet Study. J Food Nutrition 2017;12:31-40. DOI: 10.25182/jgp.2017.12.1.31-40

20.    Tarnowska-Madra U, Leibschang J, Kowalska B, Filipp E, Kozar A, Nimer A, et al. Levels of immunoreactive cytokines in serum of women with preeclampsia or severe pregnancy hypertension. Ginekol Pol 2010;81:192-6.

21.    Vitoratos N, Economou E, Iavazzo C, Panoulis K, Creatsas G. Maternal serum levels of TNF-alpha and IL-6 long after delivery in preeclamptic and normotensive pregnant women. Mediators Inflamm 2010;2010:e908649. doi: 10.1155/2010/908649.

22.    Udenze I, Amadi C, Awolola N, Makwe CC. The role of cytokines as inflammatory mediators in preeclampsia. Pan Afr Med J 2015;20:e219. doi: 10.11604/pamj.2015.20.219.5317.

23.    Mikirova N, Scimeca RC. Intravenous high-dose ascorbic acid reduces the expression of inflammatory markers in peripheral mononuclear cells of subjects with metabolic syndrome. J Transl Sci 2016;2:188-95. doi: 10.15761/JTS.1000139

24.    Ellulu MS, Rahmat A, Patimah I, Khaza'ai H, Abed Y. Effect of vitamin C on inflammation and metabolic markers in hypertensive and/or diabetic obese adults: a randomized controlled trial. Drug Des Devel Ther 2015;9:3405-12. doi: 10.2147/DDDT.S83144.

25.    Ahmad R. Introductory Chapter: Basics of Free Radicals and Antioxidants. In: Ahmad R, ed. Free Radicals, Antioxidants and Diseases. London, UK: IntechOpen Ltd, 2018. DOI: 10.5772/intechopen.76689.


Journal of the Pakistan Medical Association has agreed to receive and publish manuscripts in accordance with the principles of the following committees: